Literature DB >> 21099736

Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs.

Bethwel Raore1, Thais Federici, Jason Taub, Michael C Wu, Jonathan Riley, Colin K Franz, Michele A Kliem, Brooke Snyder, Eva L Feldman, Karl Johe, Nicholas M Boulis.   

Abstract

STUDY
DESIGN: Assessment of long-term surgical risks from multiple intraspinal cell injections.
OBJECTIVE: To prove that multilevel-targeted cell injection to the spinal cord can be a feasible and safe procedure. SUMMARY OF BACKGROUND DATA: Neural cell transplantation has been proposed as a treatment for a variety of neurologic disorders, including degenerative, ischemic, autoimmune, and traumatic etiologies. Among these diseases, the lack of effective treatment for amyotrophic lateral sclerosis has prompted the search for cell-based neuroprotection or motor neuron-replacement therapies.
METHODS: Fifteen female minipigs, divided into 3 experimental groups, underwent either 5 or 10 unilateral injections of neural stem cells or 10 vehicle injections into the C3-C5 segments of the spinal cord, using a device and technique developed for safe and accurate injection into the human spinal cord. All animals received intravenous Tacrolimus (0.025 mg/kg) BID during the course of the study. Sensory and motor functions as well as general morbidity were assessed for 28 days. Full necropsy was performed and spinal cords were analyzed for graft survival. This study was performed under Good Laboratory Practice conditions.
RESULTS: Neither mortality nor permanent surgical complications were observed within the 28-day study period. All animals returned to preoperative baseline showing full motor function recovery. Graft survival was demonstrated by immunohistochemistry.
CONCLUSION: Clinically acceptable neural progenitor survival, distribution, and density were achieved using the number of injections and surgical techniques specifically developed for this purpose.

Entities:  

Mesh:

Year:  2011        PMID: 21099736     DOI: 10.1097/BRS.0b013e3181d77a47

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  28 in total

1.  Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model.

Authors:  Daniela Ferrari; Cristina Zalfa; Laura Rota Nodari; Maurizio Gelati; Luigi Carlessi; Domenico Delia; Angelo Luigi Vescovi; Lidia De Filippis
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.

Authors:  Kevin S Chen; Stacey A Sakowski; Eva L Feldman
Journal:  Ann Neurol       Date:  2016-02-12       Impact factor: 10.422

3.  Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.

Authors:  Jonathan D Glass; Vicki S Hertzberg; Nicholas M Boulis; Jonathan Riley; Thais Federici; Meraida Polak; Jane Bordeau; Christina Fournier; Karl Johe; Tom Hazel; Merit Cudkowicz; Nazem Atassi; Lawrence F Borges; Seward B Rutkove; Jayna Duell; Parag G Patil; Stephen A Goutman; Eva L Feldman
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

4.  Establishment and Characterization of Immortalized Minipig Neural Stem Cell Line.

Authors:  Sung S Choi; Seung-Bin Yoon; Sang-Rae Lee; Sun-Uk Kim; Young Joo Cha; Daniel Lee; Seung U Kim; Kyu-Tae Chang; Hong J Lee
Journal:  Cell Transplant       Date:  2016-08-12       Impact factor: 4.064

Review 5.  Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future.

Authors:  J Simon Lunn; Stacey A Sakowski; Eva L Feldman
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

6.  Magnetic Resonance Imaging-Guided Transplantation of Neural Stem Cells into the Porcine Spinal Cord.

Authors:  Jason J Lamanna; Lindsey N Urquia; Carl V Hurtig; Juanmarco Gutierrez; Cody Anderson; Pete Piferi; Thais Federici; John N Oshinski; Nicholas M Boulis
Journal:  Stereotact Funct Neurosurg       Date:  2017-01-28       Impact factor: 1.875

Review 7.  Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.

Authors:  Young Woo Eom; Gaeun Kim; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 8.  Translational stem cell therapy for amyotrophic lateral sclerosis.

Authors:  Nicholas M Boulis; Thais Federici; Jonathan D Glass; J Simon Lunn; Stacey A Sakowski; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2011-12-13       Impact factor: 42.937

Review 9.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

10.  Surgical technique for spinal cord delivery of therapies: demonstration of procedure in gottingen minipigs.

Authors:  Thais Federici; Carl V Hurtig; Kentrell L Burks; Jonathan P Riley; Vibhor Krishna; Brandon A Miller; Eric A Sribnick; Joseph H Miller; Natalia Grin; Jason J Lamanna; Nicholas M Boulis
Journal:  J Vis Exp       Date:  2012-12-07       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.